Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.
The promotion expands Gold’s previous role as senior director of pharmaceutical development and new technology. Capabilities Gold will manage in his new ...
read more
Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University, Belfast to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis ...
read more
Thursday, January 17, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry today announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development ...
read more
When a core tablet proved too weak to withstand coating, scientists at Metrics Inc. made it stronger.
While that sounds simple enough, Metrics’ scientists tackled the problem using Quality By Design, which has been embraced by the International ...
read more
Wednesday, December 12, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
read more
Tuesday, December 11, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company’s senior director of biopharmaceutical development for its ...
read more
Tuesday, November 20, 2012
SNBL USA, Ltd., a wholly owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd., today announced it has received a formal close out letter from the U.S. Food and Drug Administration (FDA) indicating that it has successfully resolved all the ...
read more
Tuesday, November 13, 2012
Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy...
read more
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Thursday, November 01, 2012
EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced a new initiative with Sistemic Ltd., a leading provider of microRNA-based problem-solving services and kit-based products. The two companies are jointly ...
read more
With more than 2,000 drugs reintroduced for alternative purposes to date, drug repositioning has become a viable solution for pharmaceutical companies to generate additional revenue. The Intellectual Property & Science business of Thomson Reuters, ...
read more
SGS Life Science Services announced today the grand opening of its Fairfield, NJ facility, having just completed a major renovation that involved doubling the size of facility, investing in new, increased laboratory space, expanded client ...
read more
Thursday, October 18, 2012
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has been selected by AstraZeneca (NYSE: AZN) as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and ...
read more
Wednesday, September 26, 2012
Almac is pleased to announce the successful inspection of its Clinical Services operations located in Craigavon by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
read more
Wednesday, September 26, 2012
INDIGO Biosciences Inc., the premier provider of nuclear receptor products and services for the drug discovery and biosciences industries, has launched its new branding, “KNOW INDIGO,” and tagline, “The Nuclear Receptor Experts.”
read more